## TSM: Taiwan Semiconductor Manufactur - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.47 indicates fundamental undervaluation. Quality metrics strong (ROE 35%, ROA 17%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($286.89)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. TSMC (NYSE:TSM) Valuation Check After Strong Year-to-Date Share Price Run**
- Source: Simply Wall Street | 20251211T140931 | Somewhat-Bullish | Relevance: 98%
- Taiwan Semiconductor Manufacturing (TSM) has experienced a strong year-to-date performance, with shares up over 50%. While a narrative valuation suggests the stock is fairly priced at $310, a discounted cash flow (DCF) model indicates it might be trading rich at $225, raising questions about the extent of AI optimism already factored into its price. Investors face a dilemma regarding whether TSM is undervalued or already reflecting future growth.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Bernstein | $330 | $290 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Bernstein | main | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 5.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- FMR, LLC: 1.4% (+19.2%)
- JPMORGAN CHASE & CO: 0.9% (+72.6%)
- Sanders Capital, LLC: 0.6% (-15.7%)
- Capital World Invest: 0.5% (-13.0%)
- Capital Internationa: 0.5% (+0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +2.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.47 suggests fair value with growth premium. Quality metrics strong (ROE 35%, ROA 17%, margin 43%). Balance sheet: strong liquidity (2.7x), low leverage (D/E 0.46), $139.4B free cash flow. Revenue growth strong at 21% YoY. Analyst sentiment positive (1 raises, avg +14%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1581.1B |
| Beta | 1.27 |
| 52W Range | $134.25 - $313.98 |
| Short Interest | 0.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.47 |
| Forward P/E | 24.2 |
| Current P/E | 29.3 |
| YoY Growth | 20.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.4% to 3.0% (+2.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 5.2% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.32), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.99% (CS: 65) | Neutral |
| RSI_14 | 60.6 | Neutral |
| MACD Histogram | 2.32 | Bullish |
| vs SMA20 | 1.052x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.322x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $304.85
- **Stop Loss:** $286.89 (5.9% risk)
- **Target:** $340.77 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 76
- **Position Value:** $23,168.60
- **Portfolio %:** 23.17%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-15 (Est: $2.86)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.63 | $2.92 | +11.2% |
| 2025Q2 | $2.31 | $2.47 | +6.8% |
| 2025Q1 | $2.05 | $2.12 | +3.2% |
| 2024Q4 | $2.22 | $2.24 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*